Walleye Capital LLC Amyris, Inc. Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.7 - $4.05 $28,384 - $67,622	-16,697 Reduced 19.13%	70,600 $206,000
Q2 2022 Aug 08, 2022	BUY	$1.6 - $5.07 $55,220 - $174,980	34,513 Added 65.39%	87,297 $161,000
Q1 2022 May 16, 2022	SELL	$3.92 - $5.86 $531,406 - $794,399	-135,563 Reduced 71.98%	52,784 $230,000
Q4 2021 Mar 03, 2022	BUY	$5.0 - $14.85 $746,145 - $2.22 Million	149,229 Added 381.48%	188,347 $1.02 Million
Q3 2021 Nov 15, 2021	BUY	$12.13 - $16.99 $155,009 - $217,115	12,779 Added 48.52%	39,118 $537,000
Q2 2021 Aug 16, 2021	BUY	$10.82 - $19.37 $104,488 - $187,056	9,657 Added 57.89%	26,339 $431,000
Q1 2021 May 17, 2021	BUY	$7.02 - $22.62 $117,107 - $377,346	16,682 New	16,682 $319,000

230K

Ticker AMRS
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 324,860,000
Market Cap $3.25M
Description
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.